Literature DB >> 23900759

Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study.

Anna Grahn1, Staffan Nilsson, Arto Nordlund, Thomas Lindén, Marie Studahl.   

Abstract

Varicella-zoster virus (VZV) is one of the most common viruses causing central nervous system (CNS) infection, sometimes with severe neurological complications and sequelae despite appropriate antiviral treatment. Whether the neurological sequelae of VZV CNS infections include long-term cognitive impairment and how this impairment might affect the patients is still largely unknown. In this study, 14 patients with predominant CNS manifestations caused by VZV infection underwent cognitive testing 3 years (median 39.5 months, range 31-52 months) after acute disease. The results were compared with those for 28 controls, matched for age and gender. The tests covered the cognitive domains of speed and attention, memory and learning, visuospatial function, language and executive function. To further assess the cognitive dysfunction caused by neurological VZV infection, patients were classified into the concept of mild cognitive impairment (MCI), which is associated with development of dementia in other pathologies. The VZV patients performed significantly worse than controls on four tests covering the domains of speed and attention, memory and learning and executive function. The cut-off was set at 1.5 SD below mean age. In addition, a greater proportion of VZV patients were classified with MCI as compared with controls. In conclusion, patients with previous VZV infection affecting the brain had signs of long-term cognitive impairment in the domains of speed and attention, memory and learning and executive function. However, larger study populations are needed to confirm these results.

Entities:  

Mesh:

Year:  2013        PMID: 23900759     DOI: 10.1007/s00415-013-7057-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  28 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study.

Authors:  Katrin Wetzel; Isabel Asholt; Eva Herrmann; Christine Kratzer; Florian Masuhr; Eva Schielke
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

3.  Herpes zoster encephalitis.

Authors:  E APPELBAUM; S I KREPS; A SUNSHINE
Journal:  Am J Med       Date:  1962-01       Impact factor: 4.965

4.  Aging and response inhibition: Normative data for the Victoria Stroop Test.

Authors:  Angela K Troyer; Larry Leach; Esther Strauss
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2006-03

5.  The Cognitive Assessment Battery (CAB): a rapid test of cognitive domains.

Authors:  Arto Nordlund; Lisbeth Påhlsson; Christina Holmberg; Karin Lind; Anders Wallin
Journal:  Int Psychogeriatr       Date:  2011-01-21       Impact factor: 3.878

6.  Mild cognitive impairment: long-term course of four clinical subtypes.

Authors:  A Busse; A Hensel; U Gühne; M C Angermeyer; S G Riedel-Heller
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

7.  Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

Authors:  A J Mitchell; M Shiri-Feshki
Journal:  Acta Psychiatr Scand       Date:  2008-02-18       Impact factor: 6.392

8.  Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.

Authors:  Anna Grahn; Lars Hagberg; Staffan Nilsson; Kaj Blennow; Henrik Zetterberg; Marie Studahl
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

9.  Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.

Authors:  Arto Nordlund; Sindre Rolstad; Ola Klang; Karin Lind; Mona Pedersen; Kaj Blennow; Ake Edman; Stefan Hansen; Anders Wallin
Journal:  J Int Neuropsychol Soc       Date:  2008-07       Impact factor: 2.892

10.  Subcortical type cognitive impairment in herpes zoster encephalitis.

Authors:  L Hokkanen; J Launes; E Poutiainen; L Valanne; O Salonen; J Sirén; M Iivanainen
Journal:  J Neurol       Date:  1997-04       Impact factor: 6.682

View more
  8 in total

Review 1.  The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Karin Lind; Åke Edman; Mattias Göthlin; Jacob Stålhammar; Marie Eckerström; Silke Kern; Anne Börjesson-Hanson; Mårten Carlsson; Erik Olsson; Henrik Zetterberg; Kaj Blennow; Johan Svensson; Annika Öhrfelt; Maria Bjerke; Sindre Rolstad; Carl Eckerström
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Incident Herpes Zoster and Risk of Dementia: A Population-Based Danish Cohort Study.

Authors:  Sigrun Alba Johannesdottir Schmidt; Katalin Veres; Henrik Toft Sørensen; Niels Obel; Victor W Henderson
Journal:  Neurology       Date:  2022-06-08       Impact factor: 11.800

3.  Increased incidence of dementia following herpesvirus infection in the Korean population.

Authors:  YongSoo Shim; Minae Park; JaeYoung Kim
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

4.  Detection of varicella zoster virus antigen and DNA in two cases of cerebral amyloid angiopathy.

Authors:  Teresa Mescher; Philip J Boyer; Andrew N Bubak; James E Hassell; Maria A Nagel
Journal:  J Neurol Sci       Date:  2021-01-09       Impact factor: 3.181

5.  Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.

Authors:  Marie Eckerström; Staffan Nilsson; Henrik Zetterberg; Kaj Blennow; Anna Grahn
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

6.  Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.

Authors:  Jiangwei Sun; Jonas F Ludvigsson; Caroline Ingre; Fredrik Piehl; Karin Wirdefeldt; Ulrika Zagai; Weimin Ye; Fang Fang
Journal:  PLoS Med       Date:  2022-09-15       Impact factor: 11.613

Review 7.  Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer's Disease (AD); Underwhelming Evidence against.

Authors:  Ruth F Itzhaki
Journal:  Vaccines (Basel)       Date:  2021-06-21

8.  Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden.

Authors:  Karin Lopatko Lindman; Eva-Stina Hemmingsson; Bodil Weidung; Jon Brännström; Maria Josefsson; Jan Olsson; Fredrik Elgh; Peter Nordström; Hugo Lövheim
Journal:  Alzheimers Dement (N Y)       Date:  2021-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.